Source link : https://newshealth.biz/health-news/smc-accepts-first-drug-to-improve-survival-in-uveal-melanoma/
Scotland approves tebentafusp for metastatic uveal melanoma, a rare eye cancer with a median survival of around 12 months. Medscape News UK Source link : https://www.medscape.com/viewarticle/smc-accepts-first-drug-improve-survival-uveal-melanoma-2026a1000npg?src=rss Author : Publish date : 2026-07-14 10:21:00 Copyright for syndicated content belongs to the linked Source.
The post SMC Accepts First Drug to Improve Survival in Uveal Melanoma first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-14 10:21:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8